Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Blinded and unblinded internal pilot study designs for clinical trials with count data.
Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab.
Mechanisms of remyelination: recent insight from experimental models.
Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT.
Correction: Selective Blockade of CD28-Mediated T Cell Costimulation Protects Rhesus Monkeys against Acute Fatal Experimental Autoimmune Encephalomyelitis.
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.
Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits.
Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia.
Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment : Case report and review of the literature.
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis.
Epigenetic in Multiple Sclerosis: Molecular mechanisms and dietary intervention.
[The role of the solar and geomagnetic activity in the etiology of multiple sclerosis: a review of the literature and prospects of research].
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.
[Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome].
HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population.
Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1β: Investigating a Method for the Study of Fatigue in Laboratory Animals.
Neuron-macrophage crosstalk in the intestine: a "microglia" perspective.
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis.
[Structural and functional changes of the hippocampus in patients with multiple sclerosis and their relationship with memory processes].
Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion.
The Challenges, Advantages, and Future of Phenome-Wide Association Studies.
Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
Erratum: the neuroradiology journal 26: 143-150, 2013. Multiple sclerosis: identification of temporal changes in brain lesions with computer-assisted detection software.
Prompt diagnosis of multiple sclerosis should be routine, says NICE.
Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.
Pages
« first
‹ previous
…
619
620
621
622
623
624
625
626
627
…
next ›
last »